Haroulla Papaleontiou v. National Association of Boards of Pharmacy

CourtDistrict Court, E.D. New York
DecidedJune 29, 2026
Docket1:25-cv-03146
StatusUnknown

This text of Haroulla Papaleontiou v. National Association of Boards of Pharmacy (Haroulla Papaleontiou v. National Association of Boards of Pharmacy) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Haroulla Papaleontiou v. National Association of Boards of Pharmacy, (E.D.N.Y. 2026).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK

HAROULLA PAPALEONTIOU,

Plaintiff, MEMORANDUM & ORDER – against – 25-cv-03146 (NCM) (MMH)

NATIONAL ASSOCIATION OF BOARDS OF PHARMACY,

Defendant.

NATASHA C. MERLE, United States District Judge:

Plaintiff Haroulla Papaleontiou brings this action for breach of contract, negligence, negligent mispresentation, and deceptive business practices under New York General Business Law § 349 against defendant National Association of Boards of Pharmacy (“NABP”). See generally Compl. Defendant moves to dismiss all but plaintiff’s breach of contract claim and requests for certain damages. See Mot.1 For the reasons stated below, defendant’s motion is GRANTED in part, DENIED in part. BACKGROUND To become a licensed pharmacist, aspiring pharmacists must satisfy educational and training requirements as well as pass two licensing exams. Compl. ¶¶ 10–13. The first exam is the Multistate Pharmacy Jurisprudence Examination. Compl. ¶ 14. The second exam is the North American Pharmacist Licensure Examination (“NAPLEX”). Compl.

1 The Court hereinafter refers to defendant’s Brief in Support of Motion for Partial Dismissal of Plaintiff’s Complaint, ECF No. 18, as the “Motion”; plaintiff’s Memorandum of Law in Opposition to Defendant’s Motion for Partial Dismissal of the Complaint, ECF No. 21, as the “Opposition”; and defendant’s Reply in Support of Motion for Partial Dismissal of Plaintiff’s Complaint, ECF No. 22, as the “Reply.” ¶¶ 2, 14. NABP alone administers the NAPLEX, which is a standardized, computer-based exam used to assist state boards of pharmacy in evaluating a candidate’s pharmacy skills and knowledge for the purpose of issuing a pharmacist license. Compl. ¶¶ 15–17, 44. NABP is organized and exists under the laws of Kentucky, with its principal place of business in Illinois, where it is also registered to do business. Compl. ¶ 28.

To register for the NAPLEX, prospective test takers must create an account on NABP’s website and pay application fees. Compl. ¶¶ 19, 44. The NAPLEX can be taken at testing centers nationwide and is administered year-round. Compl. ¶ 20. Test scores are reported to test takers as well as to state licensing boards and pharmacy institutions designated by the test taker to receive the results. Cf. Compl. ¶ 58. On its website under the heading “Exam Results,” NABP states test takers “will receive Pass or Fail exam results approximately seven business days after you have taken the exam.” Compl. ¶ 45. NABP’s 2022 Candidate Application Bulletin states the following under the heading “Rescore Process”: “A highly rigorous process is used to ensure the accuracy of examination results, including a parallel scoring method involving independent scoring systems. Therefore, it is extremely unlikely that your exam results

will be changed as a result of the rescore process.” Compl. ¶ 42; see Decl. of Kelly Hartzler Ex. 4 (“Bulletin”), ECF No. 20 at 68–118.2 Plaintiff is a resident of New York State. Compl. ¶ 27. After completing a bachelor’s degree and a Doctor of Pharmacy, she registered to take the NAPLEX to advance her goal of becoming a licensed pharmacist. Compl. ¶¶ 1, 32. On August 20, 2022, plaintiff took

2 Throughout this Order, page numbers for docket filings refer to the page numbers assigned in ECF filing headers. the NAPLEX. Compl. ¶ 4. After taking the exam, plaintiff was informed she had failed. Compl. ¶ 35. As a result of the failing score, plaintiff lost her intern’s license and a position in a competitive residency program at NYU Langone Health, where she was going to earn an annual salary of $54,849.38. Compl. ¶¶ 3, 12, 36, 55. Plaintiff registered to retake the

NAPLEX and paid the associated fees. Compl. ¶ 60. She also spent thousands of dollars on NAPLEX tutors, preparation courses, and study aids. Compl. ¶¶ 6, 36, 60. Plaintiff took time away from work due to the additional time she devoted to studying to retake the NAPLEX. Compl. ¶¶ 55, 61. She suffered severe emotional and physical harm after receiving the incorrect failing score. Compl. ¶¶ 53, 56. Plaintiff also suffered reputational harm as a result of the incorrect failing score being reported to state licensing boards and pharmacy institutions. Compl. ¶ 58. On November 8, 2022, NABP informed plaintiff of a scoring error and that she had in fact passed the NAPLEX. Compl. ¶¶ 7, 37, 54. The scoring error resulted in incorrect scores being disseminated to approximately 220 NAPLEX test takers, including plaintiff. Compl. ¶¶ 7, 54.3 NABP had previously released incorrect scores to 400 test takers in

2021. Compl. ¶ 50. LEGAL STANDARD

3 The Court may take judicial notice of a fact outside the record that are “not subject to reasonable dispute because it . . . can be accurately and readily determined from sources whose accuracy cannot reasonably be questioned.” Fed. R. Evid. 201(b). Here, the Court will take judicial notice of Glaspie v. NABP, No. 22-cv-06497 (N.D. Ill. Nov. 19, 2022), a nationwide class action suit commenced against defendant by other NAPLEX test takers who erroneously received a failing grade in 2022. The Court also takes judicial notice that plaintiff submitted a letter to opt out of the class settlement in Glaspie. No. 22-cv-06497, ECF No. 55-1 at 4–6. Plaintiff’s opposition does not respond to defendant’s assertion on this point, and the Court considers the subject not in “reasonable dispute” between the parties. Fed. R. Evid. 201(b). When deciding a motion to dismiss, a district court must “accept[] all factual claims in the complaint as true, and draw[] all reasonable inferences in the plaintiff’s favor.” Lotes Co. v. Hon Hai Precision Indus. Co., 753 F.3d 395, 403 (2d Cir. 2014). 4 “The issue” on a motion to dismiss “is not whether a plaintiff will ultimately prevail” but instead whether a plaintiff is “entitled to offer evidence to support the claims.” Sikhs for Just. v.

Nath, 893 F. Supp. 2d 598, 615 (S.D.N.Y. 2012). Accordingly, dismissal is only appropriate if “it appears beyond doubt that the plaintiff can prove no set of facts which would entitle him or her to relief.” Sweet v. Sheahan, 235 F.3d 80, 83 (2d Cir. 2000). At the same time, plaintiff must allege sufficient facts to “nudge[] their claims across the line from conceivable to plausible.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007). “[C]onclusory allegations or legal conclusions masquerading as factual conclusions will not suffice to prevent a motion to dismiss.” Nwaokocha v. Sadowski, 369 F. Supp. 2d 362, 366 (E.D.N.Y. 2005) (quoting Smith v. Local 819 I.B.T. Pension Plan, 291 F.3d 236, 240 (2d Cir. 2002)). DISCUSSION Plaintiff brings claims for breach of contract, negligence, negligent

misrepresentation, and violation of New York General Business Law (“NYGBL”) for deceptive business practices. Compl. ¶¶ 62–107. Defendant moves to dismiss all of plaintiff’s tort claims (including the NYGBL claim), as well as plaintiff’s recovery for certain damages. See generally Mot.; Reply. Defendant does not move to dismiss plaintiff’s breach of contract claim. See Mot. 11, 11 n.5. The Court reviews defendant’s arguments with respect to each claim.

4 Throughout this Order, the Court omits all internal quotation marks, footnotes, and citations, and adopts all alterations, unless otherwise indicated. I. Tort Claims A. Negligence Defendant argues plaintiff’s negligence claim is impermissibly duplicative of her breach of contract claim and must be dismissed. Mot. 12–15.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hemi Group, LLC v. City of New York
559 U.S. 1 (Supreme Court, 2010)
City of New York v. Smokes-Spirits. Com, Inc.
541 F.3d 425 (Second Circuit, 2008)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Fink v. Time Warner Cable
714 F.3d 739 (Second Circuit, 2013)
Cruz v. FXDirectDealer, LLC
720 F.3d 115 (Second Circuit, 2013)
Goshen v. Mutual Life Insurance
774 N.E.2d 1190 (New York Court of Appeals, 2002)
Oswego Laborers' Local 214 Pension Fund v. Marine Midland Bank, N. A.
647 N.E.2d 741 (New York Court of Appeals, 1995)
J.A.O. Acquisition Corp. v. Stavitsky
863 N.E.2d 585 (New York Court of Appeals, 2007)
Kimmell v. Schaefer
675 N.E.2d 450 (New York Court of Appeals, 1996)
Bi-Economy Market, Inc. v. Harleysville Insurance
886 N.E.2d 127 (New York Court of Appeals, 2008)
Coastal Aviation, Inc. v. Commander Aircraft Co.
937 F. Supp. 1051 (S.D. New York, 1996)
Smith v. Positive Productions
419 F. Supp. 2d 437 (S.D. New York, 2005)
JP Morgan Chase Bank v. Winnick
350 F. Supp. 2d 393 (S.D. New York, 2004)
Russo v. NCS Pearson, Inc.
462 F. Supp. 2d 981 (D. Minnesota, 2006)
Nwaokocha v. Sadowski
369 F. Supp. 2d 362 (E.D. New York, 2005)
Chiste v. Hotels.com L.P.
756 F. Supp. 2d 382 (S.D. New York, 2010)
East Coast Resources, LLC v. Town of Hempstead
707 F. Supp. 2d 401 (E.D. New York, 2010)
American List Corp. v. U.S. News & World Report, Inc.
549 N.E.2d 1161 (New York Court of Appeals, 1989)

Cite This Page — Counsel Stack

Bluebook (online)
Haroulla Papaleontiou v. National Association of Boards of Pharmacy, Counsel Stack Legal Research, https://law.counselstack.com/opinion/haroulla-papaleontiou-v-national-association-of-boards-of-pharmacy-nyed-2026.